Strong Funding Momentum Acclinate recently secured $7 million in Series A funding from notable investors such as Cencora Ventures, Labcorp, and Latimer Ventures, reflecting strong investor confidence and potential for growth investment opportunities.

Recognition and Awards Being named a 2024 Fast Company Best Workplace for Innovators positions Acclinate as an innovative player in biotech, opening doors for collaborations with organizations seeking cutting-edge health equity solutions.

Community Engagement Focus Acclinate’s mission to empower underrepresented communities to improve health aligns with opportunities to offer targeted solutions, government grants, or partnerships targeting health disparities and community outreach projects.

Market Position and Growth Ranked 539 on the Inc. 5000 list and operating within the health equity space, Acclinate presents sales potential in health tech, data management, and community-based healthcare solutions as the company continues to expand.

Location and Scale Relocating headquarters to Birmingham and having a team of 51-200 employees positions Acclinate for regional expansion and partnership opportunities within the U.S. healthcare and biotech sectors.